JC

Josep Carreras Leukaemia Research Institute

Europe, Catalonia, Spain, Badalona

Description

International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.

Investor Profile

Josep Carreras Leukaemia Research Institute has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in Spain.
  • Strong thematic focus on Biotechnology, Life Science.

Stage Focus

  • Seed (100%)

Country Focus

  • Spain (100%)

Industry Focus

  • Biotechnology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Josep Carreras Leukaemia Research Institute frequently co-invest with?

ICREA
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Invivo Capital Partners
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
Clave Capital
South America, Sao Paulo, Brazil, Jardim Paulista
Co-Investments: 1
NC
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by Josep Carreras Leukaemia Research Institute?

OneChain Immunotherapeutics

Barcelona, Catalonia, Spain

OCI develops therapies for leukaemia based on CAR–T.

BiotechnologyLife Science
SeedJun 22, 2023
Amount Raised: $7,340,197
OneChain Immunotherapeutics

Barcelona, Catalonia, Spain

OCI develops therapies for leukaemia based on CAR–T.

BiotechnologyLife Science
SeedJul 27, 2020
Amount Raised: $3,589,697